The entorhinal cortex in first-episode psychotic disorders: A structural magnetic resonance imaging study

Konasale M R Prasad, Anita R. Patel, Srirangam Muddasani, John Sweeney, Matcheri S. Keshavan

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Objective: Neuropathological findings regarding the entorhinal cortex in schizophrenia are conflicting. The authors used structural magnetic resonance imaging to examine the entorhinal cortex volumes of healthy subjects and medication-naive patients experiencing their first episode of psychotic illness. Method: The study included 33 patients with schizophrenia and related disorders, 11 patients with nonschizophrenic disorders, and 43 matched healthy subjects. All subjects were rated on the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms, and volumetric measurements of the entorhinal cortex were obtained for all subjects. The authors examined differences across the groups as well as clinical correlations of entorhinal cortex volumes adjusted for intracranial volume. Results: A significant diagnosis effect was seen in the left entorhinal cortex: patients with schizophrenia and related disorders and patients with nonschizophrenic psychotic disorders had smaller left entorhinal cortex volumes than healthy subjects. The mean entorhinal cortex volume of patients with schizophrenic disorders did not differ from that of patients with nonschizophrenic psychotic disorders. In patients with schizophrenic disorders, the entorhinal cortex volume positively correlated with severity of delusions. The mean entorhinal cortex volume of patients with nondelusional psychotic disorders was significantly smaller than that of patients with delusional psychotic disorders and healthy subjects. Conclusions: Smaller entorhinal cortex volume in first-episode, neurolepticnaive psychotic disorders may not be a confound of the effects of illness chronicity or antipsychotic treatment. Entorhinal cortex pathology appears to have a significant association with positive symptoms, specifically delusions. The impairment of functions in which the entorhinal cortex participates-such as novelty detection, associative learning, and processing episodic, recognition, and autobiographical memory-could be responsible for its association with psychotic disorders and delusions.

Original languageEnglish (US)
Pages (from-to)1612-1619
Number of pages8
JournalAmerican Journal of Psychiatry
Volume161
Issue number9
DOIs
StatePublished - Sep 2004

Fingerprint

Entorhinal Cortex
Psychotic Disorders
Magnetic Resonance Imaging
Schizophrenia
Delusions
Healthy Volunteers
Episodic Memory
Paranoid Schizophrenia
Symptom Assessment
Antipsychotic Agents

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

The entorhinal cortex in first-episode psychotic disorders : A structural magnetic resonance imaging study. / Prasad, Konasale M R; Patel, Anita R.; Muddasani, Srirangam; Sweeney, John; Keshavan, Matcheri S.

In: American Journal of Psychiatry, Vol. 161, No. 9, 09.2004, p. 1612-1619.

Research output: Contribution to journalArticle

Prasad, Konasale M R ; Patel, Anita R. ; Muddasani, Srirangam ; Sweeney, John ; Keshavan, Matcheri S. / The entorhinal cortex in first-episode psychotic disorders : A structural magnetic resonance imaging study. In: American Journal of Psychiatry. 2004 ; Vol. 161, No. 9. pp. 1612-1619.
@article{b34d9dbe8ee74ad3b9848f0d39a3adca,
title = "The entorhinal cortex in first-episode psychotic disorders: A structural magnetic resonance imaging study",
abstract = "Objective: Neuropathological findings regarding the entorhinal cortex in schizophrenia are conflicting. The authors used structural magnetic resonance imaging to examine the entorhinal cortex volumes of healthy subjects and medication-naive patients experiencing their first episode of psychotic illness. Method: The study included 33 patients with schizophrenia and related disorders, 11 patients with nonschizophrenic disorders, and 43 matched healthy subjects. All subjects were rated on the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms, and volumetric measurements of the entorhinal cortex were obtained for all subjects. The authors examined differences across the groups as well as clinical correlations of entorhinal cortex volumes adjusted for intracranial volume. Results: A significant diagnosis effect was seen in the left entorhinal cortex: patients with schizophrenia and related disorders and patients with nonschizophrenic psychotic disorders had smaller left entorhinal cortex volumes than healthy subjects. The mean entorhinal cortex volume of patients with schizophrenic disorders did not differ from that of patients with nonschizophrenic psychotic disorders. In patients with schizophrenic disorders, the entorhinal cortex volume positively correlated with severity of delusions. The mean entorhinal cortex volume of patients with nondelusional psychotic disorders was significantly smaller than that of patients with delusional psychotic disorders and healthy subjects. Conclusions: Smaller entorhinal cortex volume in first-episode, neurolepticnaive psychotic disorders may not be a confound of the effects of illness chronicity or antipsychotic treatment. Entorhinal cortex pathology appears to have a significant association with positive symptoms, specifically delusions. The impairment of functions in which the entorhinal cortex participates-such as novelty detection, associative learning, and processing episodic, recognition, and autobiographical memory-could be responsible for its association with psychotic disorders and delusions.",
author = "Prasad, {Konasale M R} and Patel, {Anita R.} and Srirangam Muddasani and John Sweeney and Keshavan, {Matcheri S.}",
year = "2004",
month = "9",
doi = "10.1176/appi.ajp.161.9.1612",
language = "English (US)",
volume = "161",
pages = "1612--1619",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "9",

}

TY - JOUR

T1 - The entorhinal cortex in first-episode psychotic disorders

T2 - A structural magnetic resonance imaging study

AU - Prasad, Konasale M R

AU - Patel, Anita R.

AU - Muddasani, Srirangam

AU - Sweeney, John

AU - Keshavan, Matcheri S.

PY - 2004/9

Y1 - 2004/9

N2 - Objective: Neuropathological findings regarding the entorhinal cortex in schizophrenia are conflicting. The authors used structural magnetic resonance imaging to examine the entorhinal cortex volumes of healthy subjects and medication-naive patients experiencing their first episode of psychotic illness. Method: The study included 33 patients with schizophrenia and related disorders, 11 patients with nonschizophrenic disorders, and 43 matched healthy subjects. All subjects were rated on the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms, and volumetric measurements of the entorhinal cortex were obtained for all subjects. The authors examined differences across the groups as well as clinical correlations of entorhinal cortex volumes adjusted for intracranial volume. Results: A significant diagnosis effect was seen in the left entorhinal cortex: patients with schizophrenia and related disorders and patients with nonschizophrenic psychotic disorders had smaller left entorhinal cortex volumes than healthy subjects. The mean entorhinal cortex volume of patients with schizophrenic disorders did not differ from that of patients with nonschizophrenic psychotic disorders. In patients with schizophrenic disorders, the entorhinal cortex volume positively correlated with severity of delusions. The mean entorhinal cortex volume of patients with nondelusional psychotic disorders was significantly smaller than that of patients with delusional psychotic disorders and healthy subjects. Conclusions: Smaller entorhinal cortex volume in first-episode, neurolepticnaive psychotic disorders may not be a confound of the effects of illness chronicity or antipsychotic treatment. Entorhinal cortex pathology appears to have a significant association with positive symptoms, specifically delusions. The impairment of functions in which the entorhinal cortex participates-such as novelty detection, associative learning, and processing episodic, recognition, and autobiographical memory-could be responsible for its association with psychotic disorders and delusions.

AB - Objective: Neuropathological findings regarding the entorhinal cortex in schizophrenia are conflicting. The authors used structural magnetic resonance imaging to examine the entorhinal cortex volumes of healthy subjects and medication-naive patients experiencing their first episode of psychotic illness. Method: The study included 33 patients with schizophrenia and related disorders, 11 patients with nonschizophrenic disorders, and 43 matched healthy subjects. All subjects were rated on the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms, and volumetric measurements of the entorhinal cortex were obtained for all subjects. The authors examined differences across the groups as well as clinical correlations of entorhinal cortex volumes adjusted for intracranial volume. Results: A significant diagnosis effect was seen in the left entorhinal cortex: patients with schizophrenia and related disorders and patients with nonschizophrenic psychotic disorders had smaller left entorhinal cortex volumes than healthy subjects. The mean entorhinal cortex volume of patients with schizophrenic disorders did not differ from that of patients with nonschizophrenic psychotic disorders. In patients with schizophrenic disorders, the entorhinal cortex volume positively correlated with severity of delusions. The mean entorhinal cortex volume of patients with nondelusional psychotic disorders was significantly smaller than that of patients with delusional psychotic disorders and healthy subjects. Conclusions: Smaller entorhinal cortex volume in first-episode, neurolepticnaive psychotic disorders may not be a confound of the effects of illness chronicity or antipsychotic treatment. Entorhinal cortex pathology appears to have a significant association with positive symptoms, specifically delusions. The impairment of functions in which the entorhinal cortex participates-such as novelty detection, associative learning, and processing episodic, recognition, and autobiographical memory-could be responsible for its association with psychotic disorders and delusions.

UR - http://www.scopus.com/inward/record.url?scp=4444339443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444339443&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.161.9.1612

DO - 10.1176/appi.ajp.161.9.1612

M3 - Article

C2 - 15337651

AN - SCOPUS:4444339443

VL - 161

SP - 1612

EP - 1619

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 9

ER -